Fibrogen Stock Price History
| FGEN Stock | USD 0.46 0.04 8.00% |
Below is the normalized historical share price chart for FibroGen extending back to November 14, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of FibroGen stands at 0.46, as last reported on the 27th of February, with the highest price reaching 0.52 and the lowest price hitting 0.46 during the day.
If you're considering investing in FibroGen Stock, it is important to understand the factors that can impact its price. FibroGen appears to be dangerous, given 3 months investment horizon. FibroGen secures Sharpe Ratio (or Efficiency) of 0.0586, which denotes the company had a 0.0586 % return per unit of standard deviation over the last 3 months. By reviewing FibroGen's technical indicators, you can evaluate if the expected return of 0.53% is justified by implied risk. Please utilize FibroGen's Semi Deviation of 5.61, mean deviation of 5.91, and Downside Deviation of 7.25 to check if our risk estimates are consistent with your expectations.
At this time, FibroGen's Liabilities And Stockholders Equity is very stable compared to the past year. As of the 27th of February 2025, Issuance Of Capital Stock is likely to grow to about 63.5 M, though Total Stockholder Equity is likely to grow to (174.6 M). . As of the 27th of February 2025, Price To Sales Ratio is likely to drop to 0.64. In addition to that, Price Earnings Ratio is likely to drop to -0.29. FibroGen Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 14th of November 2014 | 200 Day MA 0.6195 | 50 Day MA 0.5136 | Beta 0.75 |
FibroGen |
Sharpe Ratio = 0.0586
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | FGEN | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 9.05 actual daily | 80 80% of assets are less volatile |
Expected Return
| 0.53 actual daily | 10 90% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average FibroGen is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of FibroGen by adding it to a well-diversified portfolio.
Price Book 53.8258 | Enterprise Value Ebitda (0.17) | Price Sales 0.2759 | Shares Float 92.9 M | Wall Street Target Price 10 |
FibroGen Stock Price History Chart
There are several ways to analyze FibroGen Stock price data. The simplest method is using a basic FibroGen candlestick price chart, which shows FibroGen price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | February 20, 2025 | 0.77 |
| Lowest Price | December 13, 2024 | 0.33 |
FibroGen February 27, 2025 Stock Price Synopsis
Various analyses of FibroGen's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell FibroGen Stock. It can be used to describe the percentage change in the price of FibroGen from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of FibroGen Stock.| FibroGen Accumulation Distribution | 211,059 | |
| FibroGen Price Rate Of Daily Change | 0.92 | |
| FibroGen Price Daily Balance Of Power | (0.67) | |
| FibroGen Price Action Indicator | (0.05) |
FibroGen February 27, 2025 Stock Price Analysis
FibroGen Stock Price History Data
The price series of FibroGen for the period between Fri, Nov 29, 2024 and Thu, Feb 27, 2025 has a statistical range of 0.44 with a coefficient of variation of 20.68. Under current investment horizon, the daily prices are spread out with arithmetic mean of 0.48. The median price for the last 90 days is 0.5. The company completed 1:1 stock split on September 8, 2009.| Open | High | Low | Close | Volume | ||
| 02/26/2025 | 0.48 | 0.52 | 0.46 | 0.46 | 1,829,180 | |
| 02/25/2025 | 0.45 | 0.52 | 0.42 | 0.50 | 4,306,296 | |
| 02/24/2025 | 0.65 | 0.65 | 0.55 | 0.58 | 5,028,090 | |
| 02/21/2025 | 0.70 | 0.79 | 0.65 | 0.71 | 9,380,399 | |
| 02/20/2025 | 0.80 | 0.88 | 0.67 | 0.77 | 122,447,970 | |
| 02/19/2025 | 0.58 | 0.59 | 0.54 | 0.56 | 709,323 | |
| 02/18/2025 | 0.57 | 0.62 | 0.55 | 0.59 | 1,146,311 | |
| 02/14/2025 | 0.53 | 0.60 | 0.51 | 0.55 | 1,354,049 | |
| 02/13/2025 | 0.46 | 0.53 | 0.46 | 0.52 | 971,647 | |
| 02/12/2025 | 0.47 | 0.48 | 0.46 | 0.46 | 685,618 | |
| 02/11/2025 | 0.50 | 0.51 | 0.47 | 0.48 | 444,618 | |
| 02/10/2025 | 0.50 | 0.51 | 0.48 | 0.50 | 278,117 | |
| 02/07/2025 | 0.50 | 0.52 | 0.49 | 0.50 | 361,883 | |
| 02/06/2025 | 0.50 | 0.52 | 0.48 | 0.50 | 592,018 | |
| 02/05/2025 | 0.45 | 0.51 | 0.45 | 0.51 | 691,539 | |
| 02/04/2025 | 0.48 | 0.48 | 0.45 | 0.46 | 609,284 | |
| 02/03/2025 | 0.47 | 0.49 | 0.45 | 0.48 | 492,281 | |
| 01/31/2025 | 0.49 | 0.51 | 0.47 | 0.48 | 322,224 | |
| 01/30/2025 | 0.48 | 0.51 | 0.47 | 0.50 | 468,702 | |
| 01/29/2025 | 0.50 | 0.50 | 0.46 | 0.48 | 617,348 | |
| 01/28/2025 | 0.50 | 0.50 | 0.48 | 0.49 | 578,630 | |
| 01/27/2025 | 0.50 | 0.54 | 0.48 | 0.49 | 749,227 | |
| 01/24/2025 | 0.51 | 0.54 | 0.50 | 0.51 | 322,211 | |
| 01/23/2025 | 0.51 | 0.55 | 0.49 | 0.51 | 677,576 | |
| 01/22/2025 | 0.53 | 0.55 | 0.46 | 0.50 | 2,471,177 | |
| 01/21/2025 | 0.56 | 0.57 | 0.53 | 0.53 | 1,099,995 | |
| 01/17/2025 | 0.56 | 0.61 | 0.52 | 0.57 | 1,273,759 | |
| 01/16/2025 | 0.60 | 0.60 | 0.55 | 0.58 | 686,674 | |
| 01/15/2025 | 0.55 | 0.61 | 0.53 | 0.60 | 763,919 | |
| 01/14/2025 | 0.59 | 0.61 | 0.51 | 0.55 | 1,057,698 | |
| 01/13/2025 | 0.60 | 0.65 | 0.55 | 0.59 | 1,447,303 | |
| 01/10/2025 | 0.65 | 0.68 | 0.59 | 0.62 | 2,432,989 | |
| 01/08/2025 | 0.62 | 0.70 | 0.57 | 0.65 | 1,663,647 | |
| 01/07/2025 | 0.68 | 0.76 | 0.61 | 0.62 | 2,632,722 | |
| 01/06/2025 | 0.57 | 0.68 | 0.57 | 0.67 | 3,206,288 | |
| 01/03/2025 | 0.53 | 0.55 | 0.49 | 0.55 | 850,685 | |
| 01/02/2025 | 0.53 | 0.60 | 0.48 | 0.53 | 2,457,917 | |
| 12/31/2024 | 0.52 | 0.54 | 0.49 | 0.53 | 921,571 | |
| 12/30/2024 | 0.58 | 0.61 | 0.51 | 0.53 | 1,525,213 | |
| 12/27/2024 | 0.58 | 0.62 | 0.50 | 0.58 | 1,887,598 | |
| 12/26/2024 | 0.50 | 0.59 | 0.49 | 0.58 | 1,973,953 | |
| 12/24/2024 | 0.50 | 0.55 | 0.48 | 0.50 | 2,222,385 | |
| 12/23/2024 | 0.41 | 0.48 | 0.40 | 0.48 | 2,606,817 | |
| 12/20/2024 | 0.35 | 0.43 | 0.35 | 0.40 | 3,372,259 | |
| 12/19/2024 | 0.34 | 0.36 | 0.34 | 0.35 | 846,051 | |
| 12/18/2024 | 0.35 | 0.37 | 0.34 | 0.34 | 818,306 | |
| 12/17/2024 | 0.35 | 0.37 | 0.33 | 0.35 | 1,425,654 | |
| 12/16/2024 | 0.32 | 0.35 | 0.31 | 0.33 | 769,076 | |
| 12/13/2024 | 0.34 | 0.35 | 0.32 | 0.33 | 1,107,400 | |
| 12/12/2024 | 0.35 | 0.37 | 0.34 | 0.34 | 474,791 | |
| 12/11/2024 | 0.37 | 0.38 | 0.35 | 0.35 | 503,872 | |
| 12/10/2024 | 0.36 | 0.38 | 0.36 | 0.36 | 648,452 | |
| 12/09/2024 | 0.35 | 0.38 | 0.35 | 0.36 | 730,067 | |
| 12/06/2024 | 0.40 | 0.40 | 0.31 | 0.34 | 2,721,894 | |
| 12/05/2024 | 0.41 | 0.42 | 0.40 | 0.41 | 453,968 | |
| 12/04/2024 | 0.41 | 0.41 | 0.39 | 0.41 | 343,610 | |
| 12/03/2024 | 0.40 | 0.43 | 0.40 | 0.41 | 575,472 | |
| 12/02/2024 | 0.41 | 0.43 | 0.39 | 0.42 | 989,920 | |
| 11/29/2024 | 0.40 | 0.43 | 0.38 | 0.42 | 1,090,632 | |
| 11/27/2024 | 0.38 | 0.39 | 0.38 | 0.39 | 428,901 | |
| 11/26/2024 | 0.40 | 0.40 | 0.38 | 0.39 | 368,395 |
About FibroGen Stock history
FibroGen investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for FibroGen is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in FibroGen will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing FibroGen stock prices may prove useful in developing a viable investing in FibroGen
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 111.9 M | 78.2 M | |
| Net Loss | -264.3 M | -251.1 M |
FibroGen Quarterly Net Working Capital |
|
FibroGen Stock Technical Analysis
FibroGen technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Stock Screener Now
Stock ScreenerFind equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
| All Next | Launch Module |
FibroGen Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for FibroGen's price direction in advance. Along with the technical and fundamental analysis of FibroGen Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of FibroGen to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0738 | |||
| Jensen Alpha | 0.762 | |||
| Total Risk Alpha | 0.8315 | |||
| Sortino Ratio | 0.1051 | |||
| Treynor Ratio | 0.6938 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in FibroGen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in FibroGen Stock, please use our How to Invest in FibroGen guide.You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of FibroGen. If investors know FibroGen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about FibroGen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.536 | Earnings Share (1.15) | Revenue Per Share | Quarterly Revenue Growth 0.154 | Return On Assets |
The market value of FibroGen is measured differently than its book value, which is the value of FibroGen that is recorded on the company's balance sheet. Investors also form their own opinion of FibroGen's value that differs from its market value or its book value, called intrinsic value, which is FibroGen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because FibroGen's market value can be influenced by many factors that don't directly affect FibroGen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between FibroGen's value and its price as these two are different measures arrived at by different means. Investors typically determine if FibroGen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, FibroGen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.